Correlation Between Monte Rosa and Agios Pharm
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and Agios Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and Agios Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and Agios Pharm, you can compare the effects of market volatilities on Monte Rosa and Agios Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of Agios Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and Agios Pharm.
Diversification Opportunities for Monte Rosa and Agios Pharm
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Monte and Agios is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and Agios Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agios Pharm and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with Agios Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agios Pharm has no effect on the direction of Monte Rosa i.e., Monte Rosa and Agios Pharm go up and down completely randomly.
Pair Corralation between Monte Rosa and Agios Pharm
Given the investment horizon of 90 days Monte Rosa Therapeutics is expected to under-perform the Agios Pharm. In addition to that, Monte Rosa is 1.81 times more volatile than Agios Pharm. It trades about -0.08 of its total potential returns per unit of risk. Agios Pharm is currently generating about 0.17 per unit of volatility. If you would invest 3,184 in Agios Pharm on November 2, 2024 and sell it today you would earn a total of 270.00 from holding Agios Pharm or generate 8.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Monte Rosa Therapeutics vs. Agios Pharm
Performance |
| Timeline |
| Monte Rosa Therapeutics |
| Agios Pharm |
Monte Rosa and Agios Pharm Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monte Rosa and Agios Pharm
The main advantage of trading using opposite Monte Rosa and Agios Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, Agios Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will offset losses from the drop in Agios Pharm's long position.| Monte Rosa vs. Nkarta Inc | Monte Rosa vs. Lyell Immunopharma | Monte Rosa vs. Generation Bio Co | Monte Rosa vs. Sana Biotechnology |
| Agios Pharm vs. Surrozen | Agios Pharm vs. Armata Pharmaceuticals | Agios Pharm vs. Pasithea Therapeutics Corp | Agios Pharm vs. Aditxt Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |